Checkpoint Inhibitor–Induced Colitis: A New Type of Inflammatory Bowel Disease?

Checkpoint inhibitors are immune-stimulatory antibodies that have transformed the management and prognosis of individuals with metastatic melanoma and other cancers. Checkpoint inhibitor–induced colitis is an increasingly recognized immune-related adverse event that shares many of the same phenotypi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bertha, Madeline, Bellaguara, Emanuelle, Kuzel, Timothy, Hanauer, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American College of Gastroenterology 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5636906/
https://www.ncbi.nlm.nih.gov/pubmed/29043290
http://dx.doi.org/10.14309/crj.2017.112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5636906/
https://www.ncbi.nlm.nih.gov/pubmed/29043290
http://dx.doi.org/10.14309/crj.2017.112

Ejemplares similares